Phase I Clinical Trials of AIDS Vaccine "Safe and Effective"

Phase I clinical trials of DNA-Tiantan AIDS vaccine, launched on December 1, 2007, has finished recently with satisfactory results, according to Shao Yiming of the National Center for AIDS Control and Prevention. The vaccine was jointly developed by the China Center for Disease Control and Prevention and the National Vaccine and Serum Institute, which holds the intellectual property rights to the serum. Trials have now entered phase II, and differ from those of the conventional design concept and technique of producing AIDS vaccine by virtue of the vaccine in question being a live serum in the form of a replicative vaccinia virus carrier.

Healthy bodily fluids and cell immunoreactions were observed to have been induced in rats and apes injected with the serum.